Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2f7
|
ENSMUSG00000020185.10 | E2F transcription factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_110760636_110760787 | E2f7 | 3145 | 0.283659 | 0.63 | 2.9e-07 | Click! |
chr10_110745577_110746010 | E2f7 | 221 | 0.948649 | 0.61 | 5.9e-07 | Click! |
chr10_110762199_110762350 | E2f7 | 1582 | 0.429523 | 0.55 | 1.5e-05 | Click! |
chr10_110762351_110762529 | E2f7 | 1416 | 0.465390 | 0.55 | 1.6e-05 | Click! |
chr10_110746800_110746951 | E2f7 | 1303 | 0.509797 | 0.53 | 3.1e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_90088341_90088533 | 10.52 |
Nrxn1 |
neurexin I |
37 |
0.99 |
chr9_81863521_81864338 | 10.17 |
Mei4 |
meiotic double-stranded break formation protein 4 |
220 |
0.95 |
chr14_5000842_5001422 | 8.85 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr4_138504549_138504859 | 8.28 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
50390 |
0.1 |
chr14_3948585_3949537 | 7.95 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr19_61225302_61226760 | 7.66 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr9_91387053_91387279 | 7.44 |
Zic4 |
zinc finger protein of the cerebellum 4 |
4756 |
0.14 |
chr15_44787967_44788147 | 7.16 |
Sybu |
syntabulin (syntaxin-interacting) |
6 |
0.8 |
chrX_113185185_113185383 | 7.04 |
Chm |
choroidermia (RAB escort protein 1) |
225 |
0.95 |
chr12_3236518_3237725 | 7.02 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr18_46211811_46211993 | 6.71 |
Trim36 |
tripartite motif-containing 36 |
705 |
0.66 |
chr10_70598782_70599169 | 6.63 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
107 |
0.98 |
chr6_36755081_36755527 | 6.52 |
Ptn |
pleiotrophin |
54875 |
0.13 |
chr19_38054215_38055320 | 6.36 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr13_31408869_31409060 | 6.34 |
G630018N14Rik |
RIKEN cDNA G630018N14 gene |
42 |
0.97 |
chr3_17790108_17790687 | 6.28 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
440 |
0.82 |
chr4_13409487_13409672 | 6.20 |
Gm11819 |
predicted gene 11819 |
35191 |
0.2 |
chr2_80129220_80129421 | 6.18 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
138 |
0.96 |
chrX_11631610_11631854 | 6.14 |
Gm14515 |
predicted gene 14515 |
30378 |
0.2 |
chr4_25799474_25800254 | 5.85 |
Fut9 |
fucosyltransferase 9 |
9 |
0.98 |
chr7_83631542_83632451 | 5.76 |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
4 |
0.6 |
chr1_88839964_88840149 | 5.74 |
Gm29337 |
predicted gene 29337 |
35354 |
0.16 |
chr11_101696402_101696749 | 5.73 |
Arl4d |
ADP-ribosylation factor-like 4D |
31034 |
0.08 |
chr13_48161346_48161520 | 5.65 |
Gm36346 |
predicted gene, 36346 |
75818 |
0.08 |
chr13_74639270_74640542 | 5.58 |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
33 |
0.97 |
chr13_12650037_12651101 | 5.55 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr3_80800657_80801686 | 5.54 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
1408 |
0.52 |
chr6_141495881_141496061 | 5.50 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
28397 |
0.2 |
chr1_22533152_22534195 | 5.47 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
21144 |
0.28 |
chr14_4854937_4855331 | 5.47 |
Gm3264 |
predicted gene 3264 |
442 |
0.76 |
chr14_4649279_4649596 | 5.37 |
Gm3239 |
predicted gene 3239 |
14755 |
0.11 |
chr5_20227973_20228279 | 5.35 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
60 |
0.98 |
chr16_88681405_88681556 | 5.32 |
Gm7667 |
predicted gene 7667 |
1248 |
0.3 |
chr19_21152051_21152232 | 5.30 |
AC106834.1 |
novel transcript |
18700 |
0.2 |
chrX_51680662_51681124 | 5.29 |
Hs6st2 |
heparan sulfate 6-O-sulfotransferase 2 |
193 |
0.96 |
chr14_93890333_93890649 | 5.27 |
Pcdh9 |
protocadherin 9 |
138 |
0.98 |
chr10_87419886_87420133 | 5.26 |
Gm23191 |
predicted gene, 23191 |
55863 |
0.12 |
chr13_13393240_13394314 | 5.25 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr14_7174792_7175177 | 5.17 |
Gm3512 |
predicted gene 3512 |
451 |
0.77 |
chr5_29735522_29736024 | 5.17 |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
85 |
0.61 |
chr3_93443881_93444908 | 5.16 |
Tchh |
trichohyalin |
2064 |
0.16 |
chr10_36507139_36507637 | 5.15 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
19 |
0.99 |
chr15_18818564_18819019 | 5.15 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr18_8871292_8871740 | 5.12 |
Gm37148 |
predicted gene, 37148 |
56719 |
0.14 |
chr3_127225478_127225684 | 5.09 |
Ank2 |
ankyrin 2, brain |
266 |
0.89 |
chr4_24966254_24966983 | 5.07 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
2 |
0.49 |
chr3_69598283_69598800 | 5.05 |
B3galnt1 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 |
419 |
0.84 |
chr11_80623402_80623553 | 5.04 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
114371 |
0.05 |
chr3_38884380_38884574 | 5.04 |
Fat4 |
FAT atypical cadherin 4 |
2463 |
0.32 |
chr11_80428777_80429451 | 5.03 |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
424 |
0.83 |
chr14_6427330_6427709 | 5.03 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
15037 |
0.14 |
chr15_97993431_97993696 | 4.98 |
Col2a1 |
collagen, type II, alpha 1 |
3087 |
0.21 |
chr13_84448589_84449243 | 4.96 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr6_134887759_134888112 | 4.94 |
Gpr19 |
G protein-coupled receptor 19 |
103 |
0.94 |
chr6_5408171_5408428 | 4.91 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
17872 |
0.23 |
chr13_90089017_90089768 | 4.87 |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
131 |
0.69 |
chr1_128590793_128591469 | 4.87 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
1159 |
0.52 |
chr13_34096148_34096452 | 4.83 |
Gm47065 |
predicted gene, 47065 |
7273 |
0.1 |
chr18_42644502_42645243 | 4.82 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
22413 |
0.16 |
chr3_107536889_107537478 | 4.78 |
Ubl4b |
ubiquitin-like 4B |
17890 |
0.15 |
chr6_148392175_148392446 | 4.76 |
Gm44022 |
predicted gene, 44022 |
981 |
0.51 |
chr14_4726126_4727100 | 4.75 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr10_25199854_25200035 | 4.72 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
214 |
0.95 |
chr4_72382561_72382773 | 4.69 |
Gm11235 |
predicted gene 11235 |
159999 |
0.04 |
chr12_106453612_106453783 | 4.66 |
Gm3191 |
predicted gene 3191 |
5453 |
0.21 |
chr8_14382927_14383159 | 4.66 |
Dlgap2 |
DLG associated protein 2 |
1047 |
0.61 |
chr5_100108777_100109262 | 4.66 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr1_20819843_20820501 | 4.62 |
Mcm3 |
minichromosome maintenance complex component 3 |
88 |
0.93 |
chr4_107739776_107740069 | 4.61 |
Gm12906 |
predicted gene 12906 |
20543 |
0.1 |
chr19_10041145_10042475 | 4.59 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr2_6884199_6884397 | 4.55 |
Gm13389 |
predicted gene 13389 |
28 |
0.83 |
chr12_33035669_33036432 | 4.50 |
Cdhr3 |
cadherin-related family member 3 |
16936 |
0.14 |
chr2_4099553_4099756 | 4.50 |
Gm38085 |
predicted gene, 38085 |
4223 |
0.14 |
chr14_4018192_4019443 | 4.48 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr4_23983504_23983750 | 4.47 |
Gm28448 |
predicted gene 28448 |
49673 |
0.19 |
chr13_83727942_83728228 | 4.45 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr14_7244047_7245236 | 4.44 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr14_8003068_8003458 | 4.44 |
Abhd6 |
abhydrolase domain containing 6 |
297 |
0.89 |
chr14_6037512_6038662 | 4.40 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr11_117497679_117497848 | 4.38 |
Gm11733 |
predicted gene 11733 |
13395 |
0.14 |
chr2_50655009_50655177 | 4.38 |
Gm13484 |
predicted gene 13484 |
2974 |
0.36 |
chr14_4110111_4111235 | 4.37 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr8_71670876_71671939 | 4.34 |
Unc13a |
unc-13 homolog A |
329 |
0.75 |
chr13_109116814_109117670 | 4.34 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
601 |
0.86 |
chr16_33605736_33606716 | 4.33 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr2_32742329_32742747 | 4.32 |
Sh2d3c |
SH2 domain containing 3C |
1046 |
0.25 |
chr1_79450325_79450959 | 4.30 |
Scg2 |
secretogranin II |
10522 |
0.24 |
chr10_20854848_20855202 | 4.29 |
Rps2-ps3 |
ribosomal protein S2, pseudogene 3 |
23948 |
0.21 |
chr18_30197959_30198135 | 4.26 |
Gm49980 |
predicted gene, 49980 |
69202 |
0.12 |
chr3_17788774_17789074 | 4.26 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
997 |
0.54 |
chr7_51622302_51622507 | 4.24 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
105 |
0.97 |
chr7_79499248_79499503 | 4.23 |
Mir9-3hg |
Mir9-3 host gene |
651 |
0.51 |
chr5_42068234_42068511 | 4.21 |
Gm16223 |
predicted gene 16223 |
412 |
0.91 |
chrX_61116287_61116454 | 4.21 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
8 |
0.49 |
chr2_43816525_43816687 | 4.20 |
Arhgap15 |
Rho GTPase activating protein 15 |
67736 |
0.14 |
chr10_10848020_10848195 | 4.20 |
4930567K20Rik |
RIKEN cDNA 4930567K20 gene |
97027 |
0.07 |
chr4_108999952_109000283 | 4.19 |
Nrd1 |
nardilysin, N-arginine dibasic convertase, NRD convertase 1 |
538 |
0.63 |
chr9_110246051_110246330 | 4.18 |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
125 |
0.94 |
chr10_21082754_21082905 | 4.18 |
Ahi1 |
Abelson helper integration site 1 |
12984 |
0.14 |
chr13_114077272_114077442 | 4.15 |
Gm47479 |
predicted gene, 47479 |
43059 |
0.16 |
chr3_5327075_5327408 | 4.12 |
Zfhx4 |
zinc finger homeodomain 4 |
85569 |
0.09 |
chr5_30072903_30073079 | 4.12 |
Tyms |
thymidylate synthase |
531 |
0.69 |
chr14_25585435_25586044 | 4.11 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
21618 |
0.17 |
chr13_105444197_105444941 | 4.09 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
930 |
0.71 |
chr10_38554173_38554374 | 4.07 |
Gm22911 |
predicted gene, 22911 |
61208 |
0.14 |
chr8_79079224_79079466 | 4.05 |
Zfp827 |
zinc finger protein 827 |
38982 |
0.16 |
chr6_94773287_94774569 | 4.05 |
Gm43997 |
predicted gene, 43997 |
25504 |
0.15 |
chr1_15805794_15806146 | 4.05 |
Terf1 |
telomeric repeat binding factor 1 |
306 |
0.89 |
chr13_81633058_81633438 | 4.04 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
94 |
0.97 |
chr10_29145120_29145386 | 4.04 |
Gm9996 |
predicted gene 9996 |
1059 |
0.37 |
chr3_107036050_107036250 | 4.03 |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
19 |
0.97 |
chr6_91284995_91285433 | 4.02 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr9_37456768_37456984 | 4.00 |
Gm47945 |
predicted gene, 47945 |
21767 |
0.1 |
chr2_112261520_112261671 | 3.99 |
Nop10 |
NOP10 ribonucleoprotein |
331 |
0.79 |
chr6_15369236_15369387 | 3.98 |
Foxp2 |
forkhead box P2 |
7378 |
0.28 |
chr15_76518669_76519134 | 3.98 |
Scrt1 |
scratch family zinc finger 1 |
3001 |
0.1 |
chr2_50128664_50128831 | 3.98 |
Lypd6 |
LY6/PLAUR domain containing 6 |
378 |
0.92 |
chrX_111462568_111463018 | 3.97 |
Rps6ka6 |
ribosomal protein S6 kinase polypeptide 6 |
154 |
0.98 |
chr17_15380918_15381780 | 3.96 |
Dll1 |
delta like canonical Notch ligand 1 |
4477 |
0.18 |
chr8_121697912_121698071 | 3.96 |
Gm45833 |
predicted gene 45833 |
23903 |
0.11 |
chr5_63767823_63768055 | 3.94 |
Nwd2 |
NACHT and WD repeat domain containing 2 |
32523 |
0.17 |
chr2_22619757_22619908 | 3.93 |
Gad2 |
glutamic acid decarboxylase 2 |
2373 |
0.21 |
chr2_106193854_106194042 | 3.89 |
Dcdc5 |
doublecortin domain containing 5 |
28109 |
0.21 |
chrX_143607023_143607174 | 3.89 |
Pak3 |
p21 (RAC1) activated kinase 3 |
57192 |
0.16 |
chr4_94361227_94361399 | 3.88 |
Gm12654 |
predicted gene 12654 |
34345 |
0.18 |
chr11_24095326_24095654 | 3.87 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
14820 |
0.14 |
chr7_71383821_71384060 | 3.87 |
Gm29328 |
predicted gene 29328 |
13607 |
0.19 |
chr12_49376760_49376940 | 3.86 |
Gm34304 |
predicted gene, 34304 |
5035 |
0.15 |
chr10_81253157_81253376 | 3.85 |
Matk |
megakaryocyte-associated tyrosine kinase |
331 |
0.69 |
chr9_37613675_37614304 | 3.85 |
Siae |
sialic acid acetylesterase |
162 |
0.63 |
chr13_96132470_96133258 | 3.84 |
Sv2c |
synaptic vesicle glycoprotein 2c |
287 |
0.67 |
chr14_5070417_5071423 | 3.80 |
Gm8281 |
predicted gene, 8281 |
120 |
0.95 |
chr2_112367678_112368469 | 3.79 |
Emc4 |
ER membrane protein complex subunit 4 |
46 |
0.96 |
chr14_3809454_3810456 | 3.77 |
Gm3002 |
predicted gene 3002 |
119 |
0.95 |
chr2_178327739_178327956 | 3.76 |
Phactr3 |
phosphatase and actin regulator 3 |
55 |
0.98 |
chr7_97842704_97842871 | 3.74 |
Pak1 |
p21 (RAC1) activated kinase 1 |
148 |
0.96 |
chr16_28445399_28445622 | 3.73 |
Fgf12 |
fibroblast growth factor 12 |
565 |
0.87 |
chr7_45460493_45461322 | 3.73 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr11_101465601_101466398 | 3.73 |
Vat1 |
vesicle amine transport 1 |
231 |
0.67 |
chr12_89148877_89149466 | 3.73 |
Nrxn3 |
neurexin III |
43935 |
0.19 |
chr1_54556878_54557293 | 3.72 |
Pgap1 |
post-GPI attachment to proteins 1 |
542 |
0.76 |
chr2_109674717_109674868 | 3.70 |
Bdnf |
brain derived neurotrophic factor |
92 |
0.95 |
chr6_50776731_50777167 | 3.70 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
625 |
0.69 |
chr13_48130669_48130883 | 3.69 |
Gm36101 |
predicted gene, 36101 |
99003 |
0.06 |
chr12_11455707_11456527 | 3.69 |
Rad51ap2 |
RAD51 associated protein 2 |
38 |
0.97 |
chr3_34642307_34643037 | 3.68 |
Gm42692 |
predicted gene 42692 |
592 |
0.6 |
chr7_96474512_96474810 | 3.66 |
Rps11-ps5 |
ribosomal protein S11, pseudogene 5 |
38644 |
0.17 |
chr5_24597183_24597664 | 3.66 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
434 |
0.68 |
chr4_22564508_22565038 | 3.62 |
Gm11881 |
predicted gene 11881 |
35764 |
0.15 |
chr4_3834860_3835883 | 3.61 |
Rps20 |
ribosomal protein S20 |
117 |
0.64 |
chr13_37969997_37970338 | 3.59 |
Rreb1 |
ras responsive element binding protein 1 |
23151 |
0.15 |
chr12_116405078_116406074 | 3.59 |
Ncapg2 |
non-SMC condensin II complex, subunit G2 |
142 |
0.76 |
chr17_56990376_56990827 | 3.58 |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
209 |
0.84 |
chr4_23636183_23636497 | 3.58 |
Gm25978 |
predicted gene, 25978 |
9595 |
0.24 |
chr1_93079597_93080373 | 3.58 |
Kif1a |
kinesin family member 1A |
2436 |
0.23 |
chr9_94410108_94410502 | 3.58 |
Gm5370 |
predicted gene 5370 |
2179 |
0.35 |
chr3_82074640_82075028 | 3.56 |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
145 |
0.96 |
chr11_48418203_48418370 | 3.56 |
Gm12178 |
predicted gene 12178 |
127973 |
0.05 |
chr2_18040855_18041062 | 3.53 |
A930004D18Rik |
RIKEN cDNA A930004D18 gene |
3221 |
0.14 |
chr5_136487718_136488180 | 3.53 |
Gm38082 |
predicted gene, 38082 |
48528 |
0.13 |
chr10_127078401_127078887 | 3.51 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
263 |
0.78 |
chrX_58030692_58030893 | 3.51 |
Zic3 |
zinc finger protein of the cerebellum 3 |
149 |
0.97 |
chr17_9543267_9543689 | 3.49 |
Gm49807 |
predicted gene, 49807 |
6213 |
0.28 |
chr2_180891097_180891925 | 3.49 |
Gm14342 |
predicted gene 14342 |
1851 |
0.17 |
chr7_109010582_109011352 | 3.48 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr13_42709181_42709490 | 3.47 |
Phactr1 |
phosphatase and actin regulator 1 |
208 |
0.96 |
chr3_18081970_18082188 | 3.47 |
Gm23726 |
predicted gene, 23726 |
12753 |
0.2 |
chr17_50006411_50007013 | 3.47 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
33885 |
0.17 |
chr4_12263404_12263560 | 3.46 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr6_125039548_125040212 | 3.46 |
Ing4 |
inhibitor of growth family, member 4 |
19 |
0.49 |
chr7_79497714_79498195 | 3.46 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr9_4795555_4796019 | 3.45 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
268 |
0.96 |
chrX_68677949_68678679 | 3.45 |
Fmr1 |
fragile X mental retardation 1 |
227 |
0.92 |
chr8_95001110_95002377 | 3.43 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
862 |
0.47 |
chr8_62575809_62576026 | 3.42 |
Gm7561 |
predicted gene 7561 |
28086 |
0.17 |
chr5_9100833_9101781 | 3.41 |
Tmem243 |
transmembrane protein 243, mitochondrial |
560 |
0.74 |
chr1_66175437_66175713 | 3.41 |
Map2 |
microtubule-associated protein 2 |
25 |
0.99 |
chr1_5019296_5020184 | 3.40 |
Rgs20 |
regulator of G-protein signaling 20 |
201 |
0.93 |
chr15_97992440_97993334 | 3.39 |
Col2a1 |
collagen, type II, alpha 1 |
2411 |
0.25 |
chr7_62348079_62348404 | 3.39 |
Ndn |
necdin |
1672 |
0.38 |
chr8_65617940_65618821 | 3.38 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr14_4181957_4182899 | 3.38 |
Gm2974 |
predicted gene 2974 |
148 |
0.94 |
chr4_119338861_119339361 | 3.37 |
Ldha-ps2 |
lactate dehydrogenase A, pseudogene 2 |
3666 |
0.13 |
chr13_83713621_83714392 | 3.37 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
7375 |
0.14 |
chr6_76977966_76978159 | 3.36 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
75174 |
0.12 |
chr19_23833848_23834052 | 3.36 |
Gm50300 |
predicted gene, 50300 |
33412 |
0.15 |
chr10_71237497_71237922 | 3.36 |
Tfam |
transcription factor A, mitochondrial |
31 |
0.97 |
chr10_3863520_3864007 | 3.35 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr15_28051385_28051581 | 3.35 |
Gm19883 |
predicted gene, 19883 |
10474 |
0.19 |
chr13_69261120_69261271 | 3.34 |
Gm4812 |
predicted gene 4812 |
84460 |
0.08 |
chr10_70640141_70640690 | 3.34 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
11510 |
0.24 |
chr1_128585767_128586184 | 3.34 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
6315 |
0.21 |
chr6_49217496_49218399 | 3.33 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
2990 |
0.21 |
chr4_22667793_22668238 | 3.32 |
Gm11879 |
predicted gene 11879 |
36042 |
0.19 |
chr11_98959522_98960759 | 3.32 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr3_62338522_62339494 | 3.32 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
9 |
0.97 |
chr12_74850478_74850629 | 3.31 |
4930442G10Rik |
RIKEN cDNA 4930442G10 gene |
7800 |
0.25 |
chr5_46445865_46446119 | 3.31 |
Gm7931 |
predicted pseudogene 7931 |
31648 |
0.22 |
chrX_21089180_21089367 | 3.30 |
Zfp300 |
zinc finger protein 300 |
44 |
0.97 |
chr5_118073321_118073637 | 3.30 |
Gm9754 |
predicted gene 9754 |
8119 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.3 | 13.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.8 | 11.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.1 | 6.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.1 | 6.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.8 | 5.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 7.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 6.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.5 | 4.6 | GO:0021586 | pons maturation(GO:0021586) |
1.4 | 2.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.4 | 5.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.3 | 10.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 8.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 4.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.3 | 5.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.2 | 2.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.2 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.2 | 3.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.2 | 5.8 | GO:0021764 | amygdala development(GO:0021764) |
1.2 | 3.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.2 | 6.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.2 | 9.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.2 | 4.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.2 | 3.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.1 | 3.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.1 | 3.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.1 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.1 | 3.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.1 | 3.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.1 | 7.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.1 | 4.3 | GO:0007412 | axon target recognition(GO:0007412) |
1.1 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.1 | 3.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.0 | 3.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.0 | 3.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.0 | 3.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.0 | 7.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.0 | 1.0 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
1.0 | 3.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.0 | 2.0 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.0 | 2.0 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.0 | 8.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.0 | 3.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.0 | 3.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.0 | 2.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 1.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.9 | 5.4 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.9 | 2.7 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.9 | 2.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 2.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.9 | 9.4 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 2.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.8 | 5.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 2.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 2.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 2.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 3.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.8 | 3.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.8 | 2.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.8 | 2.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.8 | 1.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 3.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.8 | 3.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 1.5 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 2.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.8 | 2.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 3.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 4.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 2.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.7 | 2.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 0.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.7 | 2.2 | GO:0030421 | defecation(GO:0030421) |
0.7 | 1.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.7 | 9.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 2.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 1.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.7 | 0.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.7 | 6.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 2.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 1.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.6 | 2.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 4.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.6 | 9.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.6 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 1.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 6.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 1.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.6 | 1.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 3.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.6 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 2.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 1.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 1.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 4.0 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.6 | 14.8 | GO:0001964 | startle response(GO:0001964) |
0.6 | 0.6 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.6 | 0.6 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.5 | 1.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.5 | 0.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.5 | 3.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 1.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 2.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 2.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 5.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 3.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 3.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 2.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.5 | 8.1 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 1.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 2.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 2.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 2.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.5 | 2.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.5 | 1.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 0.5 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.5 | 1.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 1.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 1.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 2.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.5 | 3.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 1.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 2.3 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 1.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 0.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 1.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.4 | 5.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 1.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.4 | 1.3 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 0.9 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.4 | 1.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.3 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.4 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.4 | 0.9 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.4 | 0.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 1.3 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.4 | 1.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 5.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 1.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 1.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 12.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 2.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 0.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 3.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 1.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 1.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 6.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 1.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 2.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 2.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 2.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 0.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 3.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.4 | 1.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 3.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 2.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 0.8 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.4 | 1.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 1.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 5.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 0.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 2.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.4 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 1.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 7.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 2.9 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 1.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 3.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 1.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 17.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 2.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 4.4 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 0.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 2.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 2.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.6 | GO:0015810 | aspartate transport(GO:0015810) malate-aspartate shuttle(GO:0043490) |
0.3 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 1.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 1.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 0.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 0.9 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 3.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 3.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 4.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 0.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 2.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 4.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.3 | 0.9 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.3 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 1.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.3 | 1.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 1.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.3 | 1.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 1.1 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 0.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 2.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 0.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 2.4 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.3 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.5 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 2.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 0.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 3.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.5 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.2 | 0.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 5.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.2 | 2.9 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.2 | 1.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 1.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.5 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.2 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 1.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 3.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.2 | 0.9 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 1.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.6 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 2.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.2 | 6.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 2.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.1 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.2 | 2.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 4.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 1.0 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.2 | 0.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 1.9 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.8 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 2.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 3.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 3.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 2.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 2.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.8 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.7 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 4.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 5.0 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 1.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 1.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 2.3 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 2.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 2.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 5.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 4.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.1 | 1.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 1.1 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.1 | 1.2 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.2 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:0002730 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 3.6 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 1.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 2.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 2.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.9 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.8 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.7 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 2.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.4 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.6 | GO:0050802 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 1.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 1.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 1.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.2 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.7 | GO:0048668 | collateral sprouting(GO:0048668) |
0.1 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.8 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 1.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.0 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.1 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.2 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 1.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.3 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 1.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.3 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0071072 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) negative regulation of phospholipid biosynthetic process(GO:0071072) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.1 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.0 | 0.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 11.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.0 | 7.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.9 | 5.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.4 | 5.7 | GO:1990696 | USH2 complex(GO:1990696) |
1.4 | 4.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.2 | 3.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 6.1 | GO:0097433 | dense body(GO:0097433) |
1.1 | 3.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.1 | 7.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.1 | 3.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 2.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 2.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 43.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 10.7 | GO:0000800 | lateral element(GO:0000800) |
0.8 | 3.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 4.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 2.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 3.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 1.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 2.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 6.4 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 2.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 15.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 4.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 4.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 2.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 1.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 1.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 3.3 | GO:0070187 | telosome(GO:0070187) |
0.5 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 6.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 3.6 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 3.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 4.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 3.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 1.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 1.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 1.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 2.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 3.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 0.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 1.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 1.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 2.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 3.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 5.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 3.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 3.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 4.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 5.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 10.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 4.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.1 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 1.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.9 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 38.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 15.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 2.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 3.4 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 2.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 3.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 3.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 18.1 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 4.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 3.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 4.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 1.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 2.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 2.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 11.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 3.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 2.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 3.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 5.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 5.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 3.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.0 | 1.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 1.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.7 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 12.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.3 | 9.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.8 | 11.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.6 | 7.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.2 | 6.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.3 | 6.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 7.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.3 | 6.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.2 | 3.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.1 | 3.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 3.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 5.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 3.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.0 | 3.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 3.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 4.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 2.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 5.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.9 | 3.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 9.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.8 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 2.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.7 | 2.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 14.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 8.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 5.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 4.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 1.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 3.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 1.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 4.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.6 | 1.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 3.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 3.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.6 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 1.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 1.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 2.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 1.6 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 2.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.5 | 2.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 3.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 1.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 2.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 2.7 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.5 | 2.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 2.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 3.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 3.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 5.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 6.2 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 1.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 3.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 0.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 5.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 1.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 3.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 12.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 4.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 4.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 3.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 1.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 2.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 7.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 9.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 2.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 3.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 4.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 6.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 3.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 3.8 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.3 | 1.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 0.9 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 2.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 2.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 2.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.8 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 8.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 2.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 10.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 2.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 3.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 3.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 4.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 2.2 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 2.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 2.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 2.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 2.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 9.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 4.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 3.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 3.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 1.9 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 2.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 3.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 2.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 2.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 1.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 6.0 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 4.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 2.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 2.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 7.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 2.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.8 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 1.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 1.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.4 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.2 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.0 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.4 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 1.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 4.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 8.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 4.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 4.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 4.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 8.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 7.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 1.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.2 | 4.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.1 | 16.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 10.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 1.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 11.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 2.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 16.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 1.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.5 | 9.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 3.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 6.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 7.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 6.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 0.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 6.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.4 | 16.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 3.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 3.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 4.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 4.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 8.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 7.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 3.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 7.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 4.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 3.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 6.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 6.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 4.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 1.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 2.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |